NCT02128906 2026-04-16
Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
University of Pittsburgh
Phase 2 Recruiting
University of Pittsburgh
Groupe Oncologie Radiotherapie Tete et Cou
University of Kentucky
Arbeitsgemeinschaft medikamentoese Tumortherapie